9 October 2013 | ARTICLE
Development and validation of COMPASS: clinical evidence of orphan medicinal products – an assessment tool BACKGROUND: Rare diseases are defined as life-threatening or chronically debilitating diseases with a prevalence of 50 out of 100,000 individuals or less. Orphan medicinal products (OMPs) are intended for the treatment of rare diseases. The assess...